Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Lisinopril in hypertension associated with renal impairment
J F Donohoe, M Laher, G D Doyle, et al.
Journal of the National Cancer Institute
|
July 1, 1983
In vitro interaction of 7,12-dimethylbenz[a]anthracene and its biliary metabolites with dietary fiber
W P Gulliver, K P Kutty, J M Laher, et al.
Respiratory Medicine
|
December 3, 1999
Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma
J Westbroek, S Saarelainen, M Laher, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1983
Baroreflex function in elderly hypertensives
K McGarry, M Laher, D Fitzgerald, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent
C P O'Boyle, M Laher, E T O'Brien, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Pharmacokinetics of amlodipine in renal impairment
G D Doyle, J Donohue, M Carmody, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension
V D'Arcy, M Laher, D McCoy, et al.
Journal of Lipid Research
|
December 1, 1984
Similar bioavailability and lymphatic transport of benzo(a)pyrene when administered to rats in different amounts of dietary fat
J M Laher, M W Rigler, R D Vetter, et al.
Acta Psychiatrica Scandinavica. Supplementum
|
January 1, 1989
The pharmacokinetics of paroxetine in renal impairment
G D Doyle, M Laher, J G Kelly, et al.
Gerontology
|
January 1, 1987
Lisinopril treatment of hypertension in patients with impaired renal function
J F Donohoe, M Laher, G D Doyle, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Lisinopril in hypertension associated with renal impairment
J F Donohoe, M Laher, G D Doyle, et al.
Journal of the National Cancer Institute
|
July 1, 1983
In vitro interaction of 7,12-dimethylbenz[a]anthracene and its biliary metabolites with dietary fiber
W P Gulliver, K P Kutty, J M Laher, et al.
Respiratory Medicine
|
December 3, 1999
Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma
J Westbroek, S Saarelainen, M Laher, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1983
Baroreflex function in elderly hypertensives
K McGarry, M Laher, D Fitzgerald, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent
C P O'Boyle, M Laher, E T O'Brien, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Pharmacokinetics of amlodipine in renal impairment
G D Doyle, J Donohue, M Carmody, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension
V D'Arcy, M Laher, D McCoy, et al.
Journal of Lipid Research
|
December 1, 1984
Similar bioavailability and lymphatic transport of benzo(a)pyrene when administered to rats in different amounts of dietary fat
J M Laher, M W Rigler, R D Vetter, et al.
Acta Psychiatrica Scandinavica. Supplementum
|
January 1, 1989
The pharmacokinetics of paroxetine in renal impairment
G D Doyle, M Laher, J G Kelly, et al.
Gerontology
|
January 1, 1987
Lisinopril treatment of hypertension in patients with impaired renal function
J F Donohoe, M Laher, G D Doyle, et al.
Page
of 3